Developing Oral LT3 Therapy for Heart Failure – HFrEF
Condition(s):Heart Failure With Reduced Ejection Fraction; Low Triiodothyronine SyndromeLast Updated:September 26, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Heart Failure With Reduced Ejection Fraction; Low Triiodothyronine SyndromeLast Updated:September 26, 2023Completed
Condition(s):Heart Failure With Preserved Ejection Fraction; Low Triiodothyronine SyndromeLast Updated:January 8, 2024Completed
Condition(s):Alzheimer’s DiseaseLast Updated:July 30, 2018Completed
Condition(s):HypothyroidismLast Updated:July 2, 2014Completed
Condition(s):Heart Defects, CongenitalLast Updated:August 5, 2013Completed
Condition(s):Metastatic Breast Cancer; Thyroid DysfunctionLast Updated:May 13, 2022Terminated
Condition(s):HypothyroidismLast Updated:July 15, 2008Completed
Condition(s):Heart FailureLast Updated:February 23, 2024Recruiting
Condition(s):Autoimmune HypothyroidismLast Updated:June 12, 2023Recruiting
Condition(s):Acne VulgarisLast Updated:March 18, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.